mRNA Research

Penn Vet launches mRNA Research Initiative

The University of Pennsylvania School of Veterinary Medicine today announced the mRNA Research Initiative to advance veterinary vaccine science.

Martin Hackett

Breaching the blood-brain barrier

A team of researchers in the School of Engineering and Applied Sciences has devised a method to deliver mRNA into the brain using lipid nanoparticles, potentially advancing treatments for Alzheimer’s disease and seizures.

Nathi Magubane

Could a single shot heal heart disease?

Experts at Penn Medicine are researching novel treatments for heart disease, including CRISPR gene editing technology, CAR T technology, and mRNA injections.

Rachel Ewing

A space for lifesaving, collaborative work

Gov. Josh Shapiro, President Liz Magill, and others from the University community celebrated the new home of the Penn Institute for RNA Innovation.

Lauren Hertzler

‘A booster for all of us’

The Penn Medicine community gathered Monday afternoon, toasting to Penn’s new Nobel laureates.

Lauren Hertzler



In the News


The Hill

mRNA vaccine by UPenn scientists could manage bird flu outbreak

Researchers led by Scott Hensley of the Perelman School of Medicine have collaborated with Drew Weissman to develop an mRNA vaccine to treat the H5N1 avian flu.

FULL STORY →



6ABC.com

Penn Medicine creates human bird flu vaccine

Researchers at Penn Medicine have created a human bird flu vaccine using mRNA, the same platform as the COVID-19 vaccine.

FULL STORY →



Fast Company

Researchers are working on a new mRNA vaccine—this time for bird flu

Researchers led by Scott Hensley of the Perelman School of Medicine are developing an mRNA vaccine for the H5N1 avian flu with support from Nobel Prize cowinner Drew Weissman.

FULL STORY →



Deutsche Welle

A vaccine for pancreatic cancer?

Drew Weissman of the Perelman School of Medicine comments on the efficacy of a potential pancreatic cancer vaccine.

FULL STORY →



Scientific American

Pancreatic cancer vaccine shows promise in small initial trial

Drew Weissman of the Perelman School of Medicine is supportive of findings about a pancreatic cancer vaccine, though he says larger studies are needed to determine effectiveness.

FULL STORY →